Riverstone Advisors, LLC Dexcom Inc Transaction History
Riverstone Advisors, LLC
- $163 Million
- Q2 2024
A detailed history of Riverstone Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Riverstone Advisors, LLC holds 21,818 shares of DXCM stock, worth $1.52 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
21,818
Previous 44,978
51.49%
Holding current value
$1.52 Million
Previous $6.24 Million
60.36%
% of portfolio
1.52%
Previous 3.72%
Shares
17 transactions
Others Institutions Holding DXCM
# of Institutions
1,112Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.25 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.41 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.14 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.07 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$834 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...